Zusammenfassung
Die chirurgischen Maßnahmen zur Behandlung des malignen Pleuramesothelioms sind Pleurektomie mit Dekortikation und extrapleurale Pneumonektomie. Die extrapleurale Pneumonektomie, historisch mit einer hohen Letalität verbunden, wird heutzutage in erfahrenen Zentren mit der gleichen Letalität wie eine Standardpneumonektomie durchgeführt. Dieser Artikel beschreibt beide Operationen und diskutiert postoperative Komplikationen, klinische Resultate und Rezidivmuster nach den entsprechenden operativen Maßnahmen. Zusätzlich werden das Stagingsystem der International Mesothelioma Interest Group (IMIG) und andere prognostische Parameter dargestellt; pathologische und epidemiologische Besonderheiten des malignen Pleuramesothelioms werden erwähnt.
Abstract
The principal surgical options for the treatment of malignant pleural mesothelioma are pleurectomy and decortication or extrapleural pneumonectomy. Although previously associated with high lethality rates, extrapleural pneumonectomy can be performed today at experienced centers with the same risk of lethality as standard pneumonectomy. This article provides a description of both surgical procedures and discusses complications, clinical results and recurrence patterns. In addition, the staging system proposed by the International Mesothelioma Interest Group (IMIG) and other prognostic parameters are detailed. Mention is also made of the pathological and epidemiological characteristics of malignant plural mesothelioma.
Literatur
Addis B, Roche H (2008) Problems in mesothelioma diagnosis. Histopathology 54:55–68
Allan K, Faber L, Warren W (1994) Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 4:113–126
Baldini EH, Recht A, Strauss GM et al (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63:334–338
Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Cancer 72:394–404
Butchart E, Ashcroft T, Barnsley W, Holden M (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 31:15–24
Chang MY, Sugarbaker DJ (2004) Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thorac Surg Clin 14:523–530
Crotty TB, Myers JL, Katzenstein ALA et al (1994) Localized malignant mesothelioma: a clinicopathologic and flow cytometric study. Am J Surg Pathol 18:357–363
DaValle M, Faber L, Kittle C, Jensik R (1986) Extrapleural pneumonectomy for diffuse, malignant mesothelioma. Ann Thorac Surg 42:612–618
Ginsberg R, Hill L, Eagan R et al (1983) Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86:654–658
Grondin S, Sugarbaker D (1999) Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. Chest 116:450S–454S
Huwer H, Winning J, Isringhaus H, Kalweit G (2006) Post-pleuropneumonectomy herniation of liver mimicking major pulmonary embolism. Asian Cardiovasc Thorac Ann 14:e60–e62
Lanphear BP, Buncher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34:718–721
La Vecchia C, Decarli A, Peto J et al (2000) An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev 9:179–184
Martini N, Bains M, Beattie Jr E (1975) Indications for pleurectomy in malignant effusion. Cancer 35:734–738
Pass HI, Kranda K, Temeck BK et al (1997) Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 4:215–222
Perrot de M, Feld R, Cho BCJ et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27:1413–1418
Politi L, De Anna D, Navarra G et al (2001) Pleuro-pneumo-phreno-pericardiectomy with pericardial and diaphragmatic plasty [Italian]. Minerva Chir 56:251–255
Rusch VW, Piantadosi S, Holmes EC (1991) The role of extrapleural pneumonectomy in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 102:1–9
Rusch VW, Saltz L, Venkatraman E et al (1994) A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12:1156–1163
Rusch VW (1996) A proposed new international TNM-staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 14:1–12
Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68:1799–1804
Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788–795
Ruth S van, Baas P, Zoetmulder FAN (2003) Surgical treatment of malignant pleural mesothelioma. Chest 123:551–561
Sarot I (1949) Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis. Thorax 4:173–223
Soysal O, Karaoglanoglu N, Demiracan S et al (1997) Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg 11:210–213
Sugarbaker DJ, Jaklitsch MT, Bueno R et al (2004) Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128:138–146
Tsao AS, Wistuba I, Roth JA, Kindler HE (2009) Malignant pleural mesothelioma. J Clin Oncol 27:2081–2090
Wagner JC, Sleggs CA, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260–271
Weder W, Opitz I, Stahel R (2009) Surgery and multimodality treatment for malignant pleural mesothelioma. Eur Respir Mon 44:407–418
Wörn H (1974) Möglichkeiten und Ergebnisse der chirurgischen Behandlung des malignen Pleuramesothelioms. Thoraxchir Vask Chir 22:391–393
Yan TD, Boyer M, Tin MM et al (2009) Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. J Thorac Cardiovasc Surg 138:619–624
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huwer, H., Bücker, A. Therapie des malignen Pleuramesothelioms. Pneumologe 7, 28–35 (2010). https://doi.org/10.1007/s10405-009-0350-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-009-0350-0